There’s a growing body of research pointing to the therapeutic applications for psychedelics, including MDMA and psilocybin, along with ketamine which was approved for therapeutic use in 2020. The promise of a new frontier in treatment for depression, anxiety and PTSD is an appealing one for researchers and patients desperately looking for solutions in a mental health crisis.

cbc.ca/listen/live-radio/1-1424-just-asking/clip/16149690-psychedelic-therapy